“…The residue was purified by column chromatography on silica gel using CHCl 3 as a eluent to afford a (737 mg, 0.81 mmol) as a white platelet crystal in % yield. Mp = 220-222°C, H NMR (600 MHz, CDCl 3 ) δ 7.69 (dd, J = 1.2, 7.8 Hz, 3H), 7.50 (dd, J = 1.2, 7.8 Hz, 3H), 7.44-7.41 (m, 3H), 7.24-7.21 (m, 3H), 13 tris(2-bromo-5-methoxyphenyl)2,4,6-tribromobenzene-1,3,5-tricarbo-xylate (7 b): Prepared according to the synthesis procedure of 7 a in 1.00 g scale and the target compound was isolated by column chromatography on silica gel using CHCl 3 /hexane (2 : 1, v/v) as the eluent to afford a white platelet crystal of 7 b (1.77 g, 1.77 mmol) in 87 % yield. Mp = 179-181°C, 1 H NMR (600 MHz, CDCl 3 ) δ 7.56 (d, J = 9.0 Hz, 3H), 7.03 (d, J = 3.0 Hz, 3H), 6.79 (dd, J = 9.0, 3.0 Hz, 3H), 3.84 (s, 9H), 13 Preparation of nanoaggregates of 1: Stock THF solutions of the 1 a and 1 b with a concentration of 10 À 3 M were prepared.…”